Detection and characterization of synthetic steroidal and non-steroidal anti-inflammatory drugs in Indian ayurvedic/herbal products using LC-MS/TOF

Drug Testing and Analysis

Volumn 1, Issue 8, 2009, Pages 372-381

  Savaliya, Akash A ^a   Prasad, Bhagwat ^a   Raijada, Dhara K ^a   Singh, Saranjit ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Adulteration; Ayurvedic herbal healthcare products; LC MS TOF; Non steroidal anti inflammatory drugs steroids

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; DRUG PRODUCTS; HEALTH CARE; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; ISOTOPES; MASS SPECTROMETERS; ULTRAVIOLET SPECTROSCOPY;

ACCURATE MASS; ADULTERATION; ANTI-INFLAMMATORY DRUGS; AYURVEDIC/HERBAL HEALTHCARE PRODUCT; EXTRACTED ION CHROMATOGRAM; HEALTHCARE PRODUCTS; LC-MS/TOF; MASS SPECTRA; NON-STEROIDAL ANTI-INFLAMMATORY DRUG STEROID; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS;

LIPIDS;

ACECLOFENAC; ACETYLSALICYLIC ACID; AYURVEDIC DRUG; BETAMETHASONE; CELECOXIB; CORTISONE; DEXAMETHASONE; DICLOFENAC; FLUDROCORTISONE; HERBACEOUS AGENT; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MEFENAMIC ACID; MELOXICAM; METHYLPREDNISOLONE; NAPROXEN; NIMESULIDE; PARACETAMOL; PHENACETIN; PIROXICAM; PREDNISOLONE; PREDNISONE; ROFECOXIB; TRIAMCINOLONE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG PURITY; DRUG QUALITY; DRUG SCREENING; ELECTROSPRAY; HUMAN; LIQUID CHROMATOGRAPHY; MASS; PRIORITY JOURNAL; STANDARD; TIME OF FLIGHT MASS SPECTROMETRY; ULTRAVIOLET RADIATION;

EID: 77953473356     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.75     Document Type: Article

References (50)

1. E. Ernst, Pharm. J. 2005, 275, 167.
2. S. K. Gupta, T. Kaleekal,S. Joshi, Pharmacoepidemiol. Drug Saf. 2000, 9, 599.
3. J. I. Boullata, A. M. Nace, Pharmacother. 2000, 20, 1.
4. E. Ernst, Pharmacoepidemiol. Drug Saf. 2004, 13, 767.
5. S. Ahmed, M. Riaz, Chromatographia 1991, 31, 67.
6. J. K. Dowman, F. H. Khattak, S. Elliott, T. M. T. Sheehan, K. A. Grindulis, Rheumatology 2006, 45, 1309.
7. T. Snyman, M. J. Stewart, A. Grove, V. Steenkamp, Ther. Drug Monit. 2005, 27, 86.
8. R. J. Ko, N. Engl. J. Med. 1998, 339, 847.
9. C. A. Ries, M. A. Sahud, JAMA 1975, 231, 352.
10. P. M. Brooks, R. M. Lowenthal, Med. J. Aust. 1977, 2, 860.
11. P. G. J. Forster, M. Calverley, S. Hubball, B. McConkey, BMJ 1979, 2, 308.
12. L. Offerhaus, M. N. G. Dukes, BMJ 1979, 2, 668.
13. R. W. Bury, R. O. Fullinfaw, D. Barraclough, K. D. Muirden, R. F. W. Moulds, T. Anghie, Med. J. Aust. 1987, 146, 324.
14. A. M. Joseph, T. Biggs, M. Garr, J. Singh, F. A. Lederle, N. Engl. J. Med. 1991, 3, 62.
15. J. O. Driscoll, A. D. Burden, T. P. Kingston, Br. J. Dermatol. 1992, 127, 543.
16. J. R. Hughes, E. M. Higgins, A. C. Pembroke, Br. J. Dermatol. 1994, 130, 261.
17. B. I. V. Stricht, O. E. Parvais, R. J. Vanhaelen-Fastré, M. H. Vanhaelen, BMJ 1994, 308, 1162.
18. R. A. C. Graham-Brown, J. F. Bourke, G. Bumphrey, BMJ 1994, 308, 473.
19. B. Wood, J. Wishart, N.Z. Med. J. 1997, 110, 420.
20. E. Gertner, P. S. Marshall, D. Filandrinos, A. S. Potek, T. M. Smith, Arthritis Rheum. 1995, 38, 614.
21. J. A. Goldman, G. Myerson, Arthritis Rheum. 1991, 34, 1207.
22. H. Hatanaku, Public Health Inst. Bull. 1984, 19, 106.
23. W. F. Huang, K. C. Wen, M. L. Hsiao, J. Clin. Pharmacol. 1997, 344.
24. F. M. Keane, S. E. Munn, A. W. P. Vivier, N. F. Taylor, E. M. Higgins, BMJ 1999, 318, 563.
25. A. B. Abt, J. Y. Oh, R. A. Huntington, K. K. Burkhart, Arch. Intern. Med. 1995, 155, 211.
26. H. L. Koh, S. O. Woo, Drug Saf. 2000, 23, 351.
27. E. Ernst, J.Inter. Med. 2002, 252, 107.
28. R. Krishnaprasad, V. V. Pillay, R. R. Rajesh, N. Vishnupriya, J. Indian Soc. Toxicol. 2005, 1, 20.
29. Y. F. Chen, H. M. Chern, M. H. Chou, M. F. Ling, Ann. Emerg. Med. 1995, 26, 717.
30. S. Singh, B. Prasad, A. A. Savaliya, R. P. Shah, V. M. Gohil, A. Kaur, Trends Anal. Chem. 2009, 28, 13.
31. J. C. Reepmeyer, J. T. Woodruff, D. A. Avingnon, J. Pharm. Biomed. Anal. 2007, 43, 1615.
32. M. J. Bogusz, H. Hassan, E. Al-Enazi, Z. Ibrahim, M. Al-Tufail, J. Pharm. Biomed. Anal. 2006, 41, 554.
33. Q. Liang, J. Qu, G. Luo, Y. Wang, J. Pharm. Biomed. Anal. 2006, 40, 305.
34. S. R. Gratz, C. L. Flurer, K. A. Wolnik, J. Pharm. Biomed. Anal. 2004, 36, 525.
35. P. Zou, S. S. Y. Oh, P. Hou, M. Y. Low, H. L. Koh, J. Chromatogr. A 2006, 1104, 113.
36. Y. P. Yuen, C. K. Lai, W. T. Poon, S. W. Ng, A. Y.W. Chan, T. W. L. Mak, Hong Kong Med. J. 2007, 13, 216.
37. J. Jung, M. Hermanns-Clausen, W. Weinmann, Forensic Sci. Int. 2006, 161, 221.
38. P. Zou, S. S. Y. Oh, K. H. Kiang, M. Y. Low, B. C. Bloodworth, Rapid Commun. Mass Spectrom. 2007, 21, 614.
39. Y. Ku, L. Chag, L. Ho, J. Lin, J. Pharm. Biomed. Anal. 2003, 33, 329.
40. H. P. Rang, M. M. Dale, J. M. Ritter, P. K. Moore, Pharmacology, 5 edn, Elsevier: New Delhi, India, 2003;, pp. 412-419.
41. H. P. Rang, M. M. Dale, J. M. Ritter, P. K. Moore, Pharmacology, 5 edn, Elsevier: New Delhi, India, 2003;, pp. 244-252.
42. D. V. Derle, K. N. Gujar, B. Sagar, Indian J. Pharm. Sci. 2006, 68, 409.
43. X. Cui, B. Shao, R. Zhao, Y. Yang, J. Hu, X. Tu, Rapid Commun. Mass Spectrom. 2006, 20, 2355.
44. A. Gentili, Trends Anal. Chem. 2007, 26, 595.
45. A. Gentili, Anal. Bioanal. Chem. 2007, 387, 1185.
46. M. Gros, M. Petrović, D. Barceló, Anal. Bioanal. Chem. 2006, 386, 941.
47. M. Petrovic, M. D. Hernando, M. S. Diaz-Cruz, D. Barcelo, J. Chromatogr. A 2005, 1067, 1.
48. A. A. M. Stolker, U. A. T. Brinkman, J. Chromatogr. A 2005, 1067, 15.
49. I. V. Chernushevich, A. V. Loboda, B. A. Thomson, J. Mass Spectrom. 2001, 36, 849.
50. ICH, Q2(R1), in: International Conference on Harmonisation, IFPMA, Geneva, 2005.